Dan S. Suesskind was Teva's Chief Financial Officer from 1977 until 2008, and a member of Teva's board from 2010 to 2014. From 2004 to 2011 he was a director of Ness Technologies Inc.
Currently, Mr. Suesskind serves as a director of several companies, including Israel Corporation Ltd., Migdal Insurance Company Ltd., and Syneron Medical Ltd., as well as a member of the board (and finance and investment committee) of the Jerusalem Foundation, a member of the Investment Committee of the Israel Academy of Science and Humanities and the Board of Trustees of the Hebrew University.
Mr. Suesskind is one of the founders and a member of the steering committee of the Israeli Forum of Chief Financial Officers. Mr. Suesskind received his B.A. in economics and political science from the Hebrew University in 1965 and an M.B.A. from the University of Massachusetts in 1969.
Michal is an experienced entrepreneur with many years of knowledge of technology startup work. She serves as Co-founder & President at Kaltura (leading provider of open source video management and delivery solutions). Michal also co-founded Cyota and was part of its management team until its acquisition by RSA Security, Inc (NASDAQ: RSAS) for $145M (US) in 2005. Michal holds a PhD in application of game theoretic models to law from NYU, and was a post-doctoral fellow at Yale Law School's Information Society Project where her research focused on Open Source, Memetics, and evolutionary game-theory. Michal also clerked at the supreme court of Israel.
Talya Miron-Shatz is Co-founder, CEO at CureMyWay, a company that develops a comprehensive platform enabling health-related consumers and their providers to structure the decision making process, overcome psychological barriers, and execute the decisions. Talya has a Ph.D in psychology from Hebrew University. She was a post-doctoral researcher at Princeton University with Daniel Kahneman, and is an Associate Professor and the Founding Director of the Center for Medical Decision Making at Ono Academic College. Talya taught consumer behavior at Wharton, University of Pennsylvania, and consulted Johnson & Johnson, Pfizer, Millicom, and other health and media companies. She publishes in books and peer reviewed journals, is a sought-after speaker at industry conferences, and her Psychology Today blog 'Baffled by Numbers' is widely read by members of the pharmaceutical industry.